ArticleCancer science2021

CDKN1C-mediated growth inhibition by an EZH1/2 dual inhibitor overcomes resistance of mantle cell lymphoma to ibrutinib.

Yuki Kagiyama et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.